Latest filing published 18 Sept 2013 for Idera Pharmaceuticals, INC., €7,587.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert W. Karr: trading record in brief
This profile gathers the share dealings of Robert W. Karr across 2 companies, led by Oncternal Therapeutics, Inc. and Idera Pharmaceuticals, Inc. We count 24 filings; the first trade dates from 1 January 2006 and the latest from 16 September 2013.
The open-market record is one-sided, with 1 purchase worth €7,587 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 23 share grants. So far in 2013, the count stands at 1 purchase and no sales.
The record was last updated on 18 September 2013 with an open-market purchase (€7,587) in Idera Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert W. Karr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,750 shares@ US$1.76Common StockSEC:0001209191-13-044741:0Canonical exit: 15 Dec 2013 (T+90)
- 139.92 shares@ US$16.08Common StockSEC:0001209191-08-021762:0
- 308.83 shares@ US$16.19Common StockSEC:0001209191-07-040058:0
- 500 shares@ US$21.21Common StockSEC:0001209191-07-014614:0
- 200 shares@ US$21.22Common StockSEC:0001209191-07-014614:1
- 63 shares@ US$21.26Common StockSEC:0001209191-07-014614:2
- 200 shares@ US$21.27Common StockSEC:0001209191-07-014614:3
- 37 shares@ US$21.28Common StockSEC:0001209191-07-014614:4
- 270.56 shares@ US$9.24Common StockSEC:0001209191-06-053549:0
- 274.73 shares@ US$9.10Common StockSEC:0001209191-06-039815:0
- 228.94 shares@ US$10.92Common StockSEC:0001209191-06-026516:0
- 330.69 shares@ US$7.56Common StockSEC:0001209191-06-001421:0
12 of 12 declarations